Testing effectiveness (Phase 2)Study completedNCT04788745
What this trial is testing
Targeting Metabolic Flexibility in Amyotrophic Lateral Sclerosis (ALS)
Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron Disease
The University of Queensland 21